Indications and Purposes
| 1 Indications And Usage Cimduo™ (Lamivudine And Tenofovir Disoproxil Fumarate) Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Human Immunodeficiency Virus Type 1 (Hiv-1) Infection In Adult And Pediatric Patients Weighing At Least 35 Kg. Cimduo Is A Two-Drug Combination Of Lamivudine (3tc) And Tenofovir Disoproxil Fumarate (Tdf), Both Nucleo(T)side Reverse Transcriptase Inhibitors And Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Human Immunodeficiency Virus Type 1 (Hiv-1) Infection In Adult And Pediatric Patients Weighing At Least 35 Kg. ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 2 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Lamivudine |
|
ZINC12346 |
| 2. Tenofovir Disoproxil Fumarate |